MycRX nominated MRX-5287 as a development candidate
The CEO discussed the company's novel approach to targeting MYC-driven cancers on Syneos Health's podcast.
Latest MycRx News & Updates
See the latest news and media coverage for MycRx. We track all announcements, press releases, and industry mentions in real time, all in one place.
Oncology biotechnology company developing direct Myc inhibitors
mycrxpharma.com- Headquarters
- Austin, United States
- Founded year
- 2013
- Company type
- Private company
- Number of employees
- 2–15
- Industry
- Pharmaceuticals
Last updated
Latest news about MycRx
Company announcements
MycRX CEO joining Tempus to discuss real-world data
Dr. Nick Glover will share how RWD informs strategy for their Myc inhibitor program.
MycRx wins Most Significant Scientific Outcome award
The Biomedical Translation Bridge Program funded the validation of small molecules directly engaging Myc.
MycRx hires an R&D Operations Manager in Melbourne for biotech drug discovery programs
The role targets ambitious, tech-savvy individuals to drive cancer patient-focused research initiatives at the Melbourne headquarters.
Media coverage
MycRX - 2025 Company Profile, Funding & Competitors - Tracxn
MycRX - Developer of small molecule inhibitors for the treatment of cancer. Raised funding from 2 investors.
Never miss news about MycRx
Track MycRx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
MycRx competitors & trending companies
Browse news for competitors to MycRx and other trending companies.
Kura
Syndax
Medivir
Novakand Pharma
Vivesto
Flapping Airplanes
Bcomp
Forciot
Carwow
CorrActions
Varjo
Circulor
enjoyelec
UVeye
Niron
Actasys
RIIICO
Leadrive
Zum
Eliq
RemotiveLabs
Breathe
dcbel
DTCC
LOT420
Hangar 420
Christina Lake Cannabis
Kronic Relief
Garden Greens
Grasshopper Farms
IndyGeneUS
Nexo
KFST
Kamstrup
Salling Group
AIS